Literature DB >> 842356

In vitro effects of rubella virus, strain RA 27/3, on human lymphocytes. I. Viral inhibition of mitogen stimulation in relation to Rubella Haemagglutination inhibition antibodies.

R Maller, L Sörén.   

Abstract

The inhibiting effect of rubella virus on lymphocyte stimulation in vitro was studied, using purified virus of the attenuated strain RA 27/3. Addition of the virus to human lymphocytes from twenty healthy blood donors before stimulation with leuco-agglutinin (LA), a component of phytohaemagglutinin, caused a considerable inhibition of the LA response in some experiments, whereas in other experiments the inhibition was slight or non-existent. If further analysed, the results showed a correlation between the degree of inhibition and the immunity of the lymphocyte donor against rubella, as measured by haemagglutination inhibition (HI). Thus the LA-response was significantly more depressed in a group of lymphocyte donors with HI-titres ranging from 20 to 160 than in another group with HI-titre less than 5. Possible explanations of the virus-induced inhibition of the LA response and possible connection between this phenomenon and the immune response against rubella are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 842356     DOI: 10.1111/j.1699-0463.1977.tb03610.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand C        ISSN: 0304-1328


  3 in total

1.  Immunosuppression and alterations of T-lymphocyte subpopulations after rubella vaccination.

Authors:  P Arneborn; G Biberfeld; J Wasserman
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

2.  Replication of rubella virus in human mononuclear blood cells.

Authors:  J T van der Logt; A M van Loon; J van der Veen
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

3.  Immunosuppression and isolation of rubella virus from human lymphocytes after vaccination with two rubella vaccines.

Authors:  E Buimovici-Klein; L Z Cooper
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.